
ABL Bio wins Eurasian patent for brain drug delivery antibody
Korean biotech ABL Bio said Monday it has secured Eurasian patent rights for a monoclonal antibody that targets the insulin-like growth factor 1 receptor (IGF1R), a protein heavily involved in controlling cell growth and metabolism. The patent, originally …